Skip to content
imbria logo (1)
  • Company
    • Mission & Values
    • Our Team
    • Board of Directors
    • Investors
    • Contact
  • Science & Pipeline
    • Pipeline
    • Ninerafaxstat
    • Publications & Presentations
  • Patients & Families
    • nHCM
    • HFpEF
    • Clinical Trials
      • Expanded Access Policy
  • Investors & Media
    • Press Releases
imbria logo (1)
  • Company
    • Mission & Values
    • Our Team
    • Board of Directors
    • Investors
    • Contact
  • Science & Pipeline
    • Pipeline
    • Ninerafaxstat
    • Publications & Presentations
  • Patients & Families
    • nHCM
    • HFpEF
    • Clinical Trials
      • Expanded Access Policy
  • Investors & Media
    • Press Releases

Board of Directors

EXPERT INSIGHT, PURPOSE-DRIVEN IMPACT

With decades of collective experience in medicine, science, and business strategy, our Board of Directors helps steer our mission to advance transformative cardiovascular therapeutics by targeting the heart’s energy metabolism.

Pavan Cheruvu
Pavan K. Cheruvu, MD

Board Chair

Andrew Levin
Andrew Levin, MD, PhD

Board Member

Charles Dunn
Charles Dunn, ACA

Board Member

Rebecca Luse
Rebecca Luse

Board Member

Zina Affas Besse, PhD

Board Member

Ken_Horne_WTB0033072_NEW
Ken Horne

Board Member

alvin c
Alvin Shih, MD

Board Member and CEO

  • Company
  • Science & Pipeline
  • Patients & Families
  • Investors & Media
  • Company
  • Science & Pipeline
  • Patients & Families
  • Investors & Media
CONTACT

Privacy Policy      Terms of Use

2025 © Imbria Pharmaceuticals​

Linkedin Twitter
 

Loading Comments...